Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04833816
Status:
RECRUITING
Last Update Posted:
2023-07-21
First Post:
2021-04-05
Brief Title:
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
Sponsor:
Assistance Publique Hopitaux De Marseille
Organization:
Assistance Publique Hopitaux De Marseille
Study Overview
Official Title:
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
KLOE
Brief Summary:
The aim of this study is to demonstrate a significant reduction of at least 25 in opioid consumption at 48 hours of management of severe trauma while demonstrating non-inferiority in terms of analgesia in a group of patients receiving a continuous infusion of low dose ketamine compared to a placebo group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2020-004812-81 | EUDRACT_NUMBER | None | None |